Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine).
| From | National Institutes of Health |
|---|---|
| Who can apply | state governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types |
| Eligibility notes | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or… |
| How much | up to $300K per award; $300K total |
| Deadline | Thu, Nov 18, 2027 (391 days left) |
| Category | Education, Health |
| Type | Grant |
| Opportunity # | RFA-DA-26-034 |
| Assistance listing | 93.233, 93.279, 93.837, 93.838, 93.839, 93.840, 93.855 |
| Posted | Wed, Nov 20, 2024 |